Latest period
$7.38B
YoY change
+16.4%
5Y CAGR
+5.3%
Peak year (2021)
$8.65B
Latest annual
$7.39B
Free Cash Flow history chart for Abbott Laboratories (ABT) from 1989 to 2025
Latest: $7.39B
Free Cash Flow growth chart for Abbott Laboratories (ABT) from 1989 to 2025
Latest: +16.4%
Free Cash Flow history table for Abbott Laboratories (ABT) from 1989 to 2025
| 2025 | $7.39B | +16.4% | +$1.04B | ||
| 2024 | $6.35B | +25.5% | +$1.29B | ||
| 2023 | $5.06B | -35.2% | −$2.75B | ||
| 2022 | $7.80B | -9.8% | −$844.00M | ||
| 2021 | $8.65B | +51.1% | +$2.92B | ||
| 2020 | $5.72B | +27.3% | +$1.23B | ||
| 2019 | $4.50B | -8.3% | −$408.00M | ||
| 2018 | $4.91B | +10.6% | +$471.00M | ||
| 2017 | $4.43B | +113.0% | +$2.35B | ||
| 2016 | $2.08B | +12.2% | +$226.00M | ||
| 2015 | $1.86B | -28.6% | −$742.00M | ||
| 2014 | $2.60B | +19.2% | +$419.00M | ||
| 2013 | $2.18B | -71.0% | −$5.34B | ||
| 2012 | $7.52B | +0.5% | +$40.53M | ||
| 2011 | $7.48B | -3.1% | −$242.33M | ||
| 2010 | $7.72B | +24.8% | +$1.53B | ||
| 2009 | $6.19B | +2.1% | +$129.65M | ||
| 2008 | $6.06B | +71.7% | +$2.53B | ||
| 2007 | $3.53B | -11.6% | −$463.79M | ||
| 2006 | $3.99B | +0.6% | +$24.50M | ||
| 2005 | $3.97B | +27.3% | +$850.61M | ||
| 2004 | $3.12B | +24.7% | +$616.60M | ||
| 2003 | $2.50B | -13.4% | −$386.84M | ||
| 2002 | $2.89B | +20.1% | +$483.41M | ||
| 2001 | $2.40B | +16.4% | +$339.40M | ||
| 2000 | $2.06B | +5.8% | +$113.32M | ||
| 1999 | $1.95B | +30.9% | +$460.22M | ||
| 1998 | $1.49B | +5.0% | +$71.03M | ||
| 1997 | $1.42B | -1.0% | −$13.89M | ||
| 1996 | $1.43B | -27.1% | −$532.52M | ||
| 1995 | $1.97B | -11.1% | −$246.56M | ||
| 1994 | $2.21B | +19.8% | +$365.23M | ||
| 1993 | $1.85B | +384.0% | +$1.47B | ||
| 1992 | $381.60M | -44.1% | −$301.00M | ||
| 1991 | $682.60M | +22.0% | +$123.10M | ||
| 1990 | $559.50M | +44.6% | +$172.70M | ||
| 1989 | $386.80M | — | — |
- 2025$7.39B+16.4%
- 2024$6.35B+25.5%
- 2023$5.06B-35.2%
- 2022$7.80B-9.8%
- 2021$8.65B+51.1%
- 2020$5.72B+27.3%
- 2019$4.50B-8.3%
- 2018$4.91B+10.6%
- 2017$4.43B+113.0%
- 2016$2.08B+12.2%
- 2015$1.86B-28.6%
- 2014$2.60B+19.2%
- 2013$2.18B-71.0%
- 2012$7.52B+0.5%
- 2011$7.48B-3.1%
- 2010$7.72B+24.8%
- 2009$6.19B+2.1%
- 2008$6.06B+71.7%
- 2007$3.53B-11.6%
- 2006$3.99B+0.6%
- 2005$3.97B+27.3%
- 2004$3.12B+24.7%
- 2003$2.50B-13.4%
- 2002$2.89B+20.1%
- 2001$2.40B+16.4%
- 2000$2.06B+5.8%
- 1999$1.95B+30.9%
- 1998$1.49B+5.0%
- 1997$1.42B-1.0%
- 1996$1.43B-27.1%
- 1995$1.97B-11.1%
- 1994$2.21B+19.8%
- 1993$1.85B+384.0%
- 1992$381.60M-44.1%
- 1991$682.60M+22.0%
- 1990$559.50M+44.6%
- 1989$386.80M—
Free Cash Flow values are taken from Abbott Laboratories's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Abbott Laboratories (ABT)
Free Cash Flow for Abbott Laboratories (ABT): headline value $7.38B · YoY +16.4%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Abbott Laboratories (ABT) free cash flow totalled $7.39B – grew 16.4% year-over-year.
Through 2020–2025 (5 years), Abbott Laboratories free cash flow delivered a +5.3% annualised rate; sustaining 2 straight years of year-over-year growth.
Abbott Laboratories free cash flow peaked at $8.65B in 2021; the latest annual figure is $7.39B in 2025 (14.5% below peak).
2021 marks the peak free cash flow at $8.65B, with the historical low of $381.60M recorded in 1992.
Abbott Laboratories Free Cash Flow by Year
Abbott Laboratories Free Cash Flow 2025: $7.39B
2025's free cash flow for Abbott Laboratories came in at $7.39B, grew 16.4% from 2024.
Abbott Laboratories Free Cash Flow 2024: $6.35B
Abbott Laboratories posted free cash flow of $6.35B in 2024, grew 25.5% from 2023.
Abbott Laboratories Free Cash Flow 2023: $5.06B
In 2023, Abbott Laboratories reported free cash flow of $5.06B, plunged 35.2% below 2022.
Abbott Laboratories Free Cash Flow 2022: $7.80B
Abbott Laboratories free cash flow in 2022 was $7.80B, declined 9.8% below 2021.
Abbott Laboratories Free Cash Flow 2021: $8.65B
Abbott Laboratories free cash flow in 2021 was $8.65B.
See more financial history for Abbott Laboratories (ABT).
Sector peers by Free Cash Flow
Healthcare peers of Abbott Laboratories (ABT), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $8.97B | |
| $8.67B | |
| $8.10B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $8.97B
- $8.67B
- $8.10B
- $4.52B
Frequently asked questions
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation